Generics 151

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexamethasone sodium phosphate manufacturers

151 products found

Filters

151 products found

dexamethasone sodium phosphate + ofloxacin

Ear/eye drops 1 mg/ml + 3 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

dexamethasone sodium phosphate

Ear/eye drops 1 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

dexamethasone sodium phosphate

Eye gel 1.5mg/ml - 0.4ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10238
A pharmaceutical manufacturer based in Europe that has been active in 20+ countries selling its products for 80+ years. Key production lines are Rx, medical devices, and nutraceuticals. The main therapeutic areas include ophthalmology. The company has branches in Europe and LATAM.

Manufacturer usually replies in 7 days

dexamethasone sodium phosphate

Eye drops 1.5mg/ml - 0.3ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10238
A pharmaceutical manufacturer based in Europe that has been active in 20+ countries selling its products for 80+ years. Key production lines are Rx, medical devices, and nutraceuticals. The main therapeutic areas include ophthalmology. The company has branches in Europe and LATAM.

Manufacturer usually replies in 7 days

dexamethasone sodium phosphate + chloramphenicol

Eye drops 0.1 % + 0.5 % - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Austria , Belgium , Bosnia And Herzegovina , Bulgaria , Croatia , Cyprus , Denmark , Estonia , Finland , France , Germany , Hungary , Ireland , Italy , Latvia , North Macedonia , Moldova , Netherlands , Norway , Poland , Portugal , Romania , Serbia , Slovakia , Slovenia , Spain , Sweden , Switzerland , United Kingdom , Iraq , United Arab Emirates
Available for
Licensing with supply
Manufacturer #9267

A highly trusted and reliable name for WHO-approved pharmaceutical products that deals in exports as well. With modern facilities and excellent product conditions, they are known to provide superlative services aimed at keeping the community disease-free and healthy at the same time.

Manufacturer usually replies in 8 days

dexamethasone sodium phosphate

Vials, injection 4mg / 1ml, 8mg / 2ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #8838
A pharmaceutical manufacturer based in Europe that has been selling its products in Europe and CIS for 40+ years. Main therapeutic areas include gynecology and dermatology. Key production lines are Rx, medical devices, cosmetics, and nutraceuticals. Main dosage forms include oral solids, oral liquids, and injectable. The company's production lines are GMP-compliant.

Manufacturer usually replies in 16 days

dexamethasone sodium phosphate

Oral drops 0.2% - 10ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #8838
A pharmaceutical manufacturer based in Europe that has been selling its products in Europe and CIS for 40+ years. Main therapeutic areas include gynecology and dermatology. Key production lines are Rx, medical devices, cosmetics, and nutraceuticals. Main dosage forms include oral solids, oral liquids, and injectable. The company's production lines are GMP-compliant.

Manufacturer usually replies in 16 days

dexamethasone sodium phosphate

Vials, injection 10 mg / 1 ml, 100 mg / 10 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18871

Manufacturer usually replies in 4 days

dexamethasone sodium phosphate

Solution for injection 4 mg/ ml - 1 ml, 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

dexamethasone sodium phosphate + chloramphenicol

Eye drops 1 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

dexamethasone sodium phosphate

Injection 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #20788

Manufacturer usually replies in 2 days

dexamethasone sodium phosphate

Injection 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

dexamethasone sodium phosphate

Eye drops 1 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Honduras
GMP approvals
WHO
Manufacturer #18605

Manufacturer usually replies in 5 days

dexamethasone sodium phosphate

Vials, injection 4 mg / 1 mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Honduras
GMP approvals
WHO
Manufacturer #18605

Manufacturer usually replies in 5 days

dexamethasone sodium phosphate

Vials, injection 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750

Manufacturer usually replies in 4 days

dexamethasone sodium phosphate + naphazoline

Eye drops 0,1%, 0,012%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #15158
They are a contemporary pharmaceutical laboratory with over 70 years of market experience in Latin America. They hold a certificate from INVIMA, the country's highest authority for pharmaceutical control, per WHO Good Manufacturing Practices (GMP) (report 32).

Manufacturer usually replies in 3 days

dexamethasone sodium phosphate

Solution for injection 4mg/ml; pack size: 5, 25, 100

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
WHO
Manufacturer #9289
A pharmaceutical manufacturer based in Europe that has been active in 30+ countries selling its products in Europe, the Middle East, Africa, CIS, and Asia for 30+ years. The main therapeutic areas include gynecology, cardiology, urology, and antiviral. Key production lines are Rx Main dosage forms include solids, liquids, and injectables. The company's production lines are GMP-compliant.

Manufacturer usually replies in 4 days

dexamethasone sodium phosphate

Ampoules, injection 8 mg/2 ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #274

Manufacturer usually replies in 1 days

dexamethasone sodium phosphate

Injection 4mg/ml, 8mg/2ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #1027

Manufacturer usually replies in 4 days

dexamethasone sodium phosphate

Solution for injection 4mg/ml

Dossier type
CTD
Dossier status
Under development
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17805

Manufacturer usually replies in 2 days

Want to view all 151 products? Create your free account today!

Dexamethasone sodium phosphate

Corticosteroids are a class of drugs that helps in lowering the inflammation in the body. These ease allergic reactions, redness, itching, and swelling. Dexamethasone also belongs to this class of medications. The manufacturers offer it in the form of an oral drug or an injection. Dexamethasone has found to be promising in easing inflammation symptoms in the body. It has been established in clinical trials. It is preferred in the treatment of severe allergies and rheumatic problems.

History and cost of Dexamethasone sodium phosphate

Dexamethasone was first synthesized in 1957. Its medical use commenced in 1961. It has been listed by the WHO as one of the most effective and safest medicines required in a health system. This drug is not expensive. The cost of the monthly dose of this drug is anywhere around £20. The wholesale cost varies based on the manufacturer and the combination of this drug being offered.

Medical use of Dexamethasone sodium phosphate

There are numerous beneficial benefits of taking dexamethasone. Anti-inflammatory Dexamethasone is used in the treatment of autoimmune and inflammatory conditions. It is given in a small dosage during dental surgery such as while extracting the wisdom teeth. It is also prescribed for treating croup in children. A single dose can prove to be beneficial in reducing discomfort and improving breathing. Cancer Patients with cancer undergoing a chemotherapy procedure are given dexamethasone for counteracting the side effects. This drug can increase the antiemetic effect of 5-HT3 receptor antagonists. However, the exact mechanism is not well understood. The drug is also beneficial in the case of brain tumors for counteracting the development of edema. Endocrine Dexamethasone is used in the treatment of rare endocrine disorders such as glucocorticoid resistance. It is also prescribed when a patient is not responding to Addison’s disease treatment and adrenal insufficiency. Pregnancy Dexamethasone can be given to a woman who is at the risk of delivering a baby prematurely. This drug promotes the maturation of the lungs of a fetus. It is also recommended for off-label prenatal treatment of congenital adrenal hyperplasia in female babies. Veterinary use Dexamethasone sodium phosphate manufacturers also offer it under the trade name Aurizon. This is used for treating ear infections in dogs. It is also given to horses in combination with other drugs for treating general bruising and swelling of distal limbs.

How to find reliable Dexamethasone sodium phosphate suppliers?

Distributors who are keen on finding reliable Dexamethasone sodium phosphate suppliers should register on the Pipelinepharma platform. This platform has made it easier for distributors to connect with the leading manufacturers in the pharma industry. Assistance is offered throughout while negotiating the terms of the contract. All the manufacturers listed on the platform have been verified for their quality. Convenient search filters offered by the platform make it quite convenient to find Dexamethasone sodium phosphate manufacturers. There are filters for the country, dossier status, GMP approvals, wholesale cost, and a lot more. This will help you shortlist a manufacturer based on your requirements.